Abstract
Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
Barry Bresnihan, Richard Newmark, Sean Robbins and Harry K Genant
The Journal of Rheumatology June 2004, 31 (6) 1103-1111;
Barry Bresnihan
Richard Newmark
Sean Robbins
In this issue
Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
Barry Bresnihan, Richard Newmark, Sean Robbins, Harry K Genant
The Journal of Rheumatology Jun 2004, 31 (6) 1103-1111;